Multiple myeloma (extraosseous manifestations)

Changed by Avni K P Skandhan, 24 Feb 2018

Updates to Article Attributes

Body was changed:

Extraosseous myeloma refers to any manifestation of multiple myeloma where there is plasma cell proliferation outside the skeletal system. This can potentially affect any organ system and the reported disease spectrum includes:

  • reticulo-endothelialreticuloendothelial system
    • lymph nodes (considered to be most common site 1)
  • central nervous system (CNS) involvement independent of bone is thought to occur in less than 1% of multiple myeloma 1
    • leptomeningeal involvement: considered the commonest form of CNS involvement
  • thorax
    • lung
      • pulmonary nodules
      • interstitial infiltrates
    • pleura
      • can manifest as a pleural effusion or pleural thickening
  • abdomen
    • liver
      • thought to be most common solid organ involved in the abdomen 7
      • involvement of the liver can occur as diffuse sinusoidal infiltration or as distinct nodules
    • mesenteric: omental masses
    • pancreas
    • renal involvement
      • peri-renal space: can a relatively common occurrence in the abdomen 10
        • peri-renal nodules: can mimic melanoma metastases 3
        • peri-renal soft tissue thickening
      • intra-renal lesions
  • other sites
    • subcutaneous tissues
    • skin
    • breast tissue
    • testis 7
    • orbit 5-6

Epidemiology

The overall incidence is thought to be around 5-16% on those diagnosed with myeloma 3,7-8. It is considered to be more common in younger patients and in those with non secretory-secretory myeloma and IgD myeloma 3.

Radiographic features 

Imaging features are non-specific and widely variable dependent on site. The condition can mimic other pathologies.

General image interpretation guideline

When there is known background multiple myeloma, the development of focal soft-tissue masses should be considered highly suspicious for extraosseous myeloma. In particular, the development of extraosseous soft-tissue masses in a myeloma patient after stem cell transplantation should raise suspicion for extraosseous myeloma. It is important to know if there is more than one lesion.

Diagnosis

In most cases, especially patients with a coexisting malignancy, tissue diagnosis is often considered essential.

Treatment and prognosis

The presence of extraosseous myeloma generally implies a poorer prognosis 3. More content required on treatment.

Differential diagnosis

Extra-osseous myeloma can mimic a vast number of entities dependent on location.

If there is only one lesion and the lesion reveals myelomatous / plasma cells on a biopsy, consider extramedullary plasmacytoma.

  • -<li>reticulo-endothelial system<ul><li>lymph nodes (considered to be most common site <sup>1</sup>)</li></ul>
  • +<li>reticuloendothelial system<ul><li>lymph nodes (considered to be most common site <sup>1</sup>)</li></ul>
  • -</ul><h4>Epidemiology</h4><p>The overall incidence is thought to be around 5-16% on those diagnosed with myeloma <sup>3,7-8</sup>. It is considered to be more common in younger patients and in those with <a href="/articles/non-secretory-myeloma">non secretory myeloma</a> and <a href="/articles/igd-myeloma">IgD myeloma</a> <sup>3</sup>.</p><h4>Radiographic features </h4><p>Imaging features are non-specific and widely variable dependent on site. The condition can mimic other pathologies.</p><h5>General image interpretation guideline</h5><p>When there is known background multiple myeloma, the development of focal soft-tissue masses should be considered highly suspicious for extraosseous myeloma. In particular, the development of extraosseous soft-tissue masses in a myeloma patient after stem cell transplantation should raise suspicion for extraosseous myeloma. It is important to know if there is more than one lesion.</p><h4>Diagnosis</h4><p>In most cases, especially patients with a coexisting malignancy, tissue diagnosis is often considered essential.</p><h4>Treatment and prognosis</h4><p>The presence of extraosseous myeloma generally implies a poorer prognosis <sup>3</sup>. More content required on treatment.</p><h4>Differential diagnosis</h4><p>Extra-osseous myeloma can mimic a vast number of entities dependent on location.</p><p>If there is only one lesion and the lesion reveals myelomatous / plasma cells on biopsy, consider <a href="/articles/extramedullary-plasmacytoma">extramedullary plasmacytoma</a>.</p>
  • +</ul><h4>Epidemiology</h4><p>The overall incidence is thought to be around 5-16% on those diagnosed with myeloma <sup>3,7-8</sup>. It is considered to be more common in younger patients and in those with <a href="/articles/non-secretory-myeloma">non-secretory myeloma</a> and <a href="/articles/igd-myeloma">IgD myeloma</a> <sup>3</sup>.</p><h4>Radiographic features </h4><p>Imaging features are non-specific and widely variable dependent on site. The condition can mimic other pathologies.</p><h5>General image interpretation guideline</h5><p>When there is known background multiple myeloma, the development of focal soft-tissue masses should be considered highly suspicious for extraosseous myeloma. In particular, the development of extraosseous soft-tissue masses in a myeloma patient after stem cell transplantation should raise suspicion for extraosseous myeloma. It is important to know if there is more than one lesion.</p><h4>Diagnosis</h4><p>In most cases, especially patients with a coexisting malignancy, tissue diagnosis is often considered essential.</p><h4>Treatment and prognosis</h4><p>The presence of extraosseous myeloma generally implies a poorer prognosis <sup>3</sup>. More content required on treatment.</p><h4>Differential diagnosis</h4><p>Extra-osseous myeloma can mimic a vast number of entities dependent on location.</p><p>If there is only one lesion and the lesion reveals myelomatous / plasma cells on a biopsy, consider <a href="/articles/extramedullary-plasmacytoma">extramedullary plasmacytoma</a>.</p>

Sections changed:

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.